Optical coherence tomography in the diagnosis of optic pathway gliomas.
暂无分享,去创建一个
E. Trevisson | M. Clementi | E. Pilotto | E. Midena | R. Parrozzani | G. Orlando | O. Kotsafti | G. Miglionico
[1] D. Gutmann,et al. Modeling cognitive dysfunction in neurofibromatosis-1 , 2013, Trends in Neurosciences.
[2] R. Packer,et al. Feasibility and comparison of visual acuity testing methods in children with neurofibromatosis type 1 and/or optic pathway gliomas. , 2013, Investigative ophthalmology & visual science.
[3] Yuquan Wen,et al. Normative reference ranges for the retinal nerve fiber layer, macula, and retinal layer thicknesses in children. , 2013, American journal of ophthalmology.
[4] K. North,et al. The Impact of ADHD on the Cognitive and Academic Functioning of Children With NF1 , 2012, Developmental neuropsychology.
[5] E. Pasmant,et al. Neurofibromatosis type 1: from genotype to phenotype , 2012, Journal of Medical Genetics.
[6] G. Quinn,et al. Retinal nerve fiber layer thickness in children with optic pathway gliomas. , 2011, American journal of ophthalmology.
[7] T. Young,et al. Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas. , 2010, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.
[8] J. Ortenberg,et al. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients. , 2010, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.
[9] S. Huson,et al. Birth incidence and prevalence of tumor‐prone syndromes: Estimates from a UK family genetic register service , 2010, American journal of medical genetics. Part A.
[10] S. Azen,et al. Visual Acuity Norms in Pre-School Children: The Multi-Ethnic Pediatric Eye Disease Study , 2009, Optometry and vision science : official publication of the American Academy of Optometry.
[11] C. Westall,et al. Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials. , 2007, Investigative ophthalmology & visual science.
[12] D. Gutmann,et al. Optic pathway gliomas in neurofibromatosis‐1: Controversies and recommendations , 2007, Annals of neurology.
[13] D. Evans,et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1 , 2006, Journal of Medical Genetics.
[14] R. Hoffman,et al. Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing? , 2006, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.
[15] W. Kaiser,et al. Pediatric brain MRI in neurofibromatosis type I , 2005, European Radiology.
[16] N. Miller,et al. Primary tumours of the optic nerve and its sheath , 2004, Eye.
[17] Y. Kalish,et al. Swedish interactive thresholding algorithm fast for following visual fields in prepubertal idiopathic intracranial hypertension. , 2004, Ophthalmology (Rochester, Minn.).
[18] G. Quinn,et al. Threshold visual acuity testing of preschool children using the crowded HOTV and Lea Symbols acuity tests. , 2003, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.
[19] L. Cyert. Preschool Visual Acuity Screening with HOTV and Lea Symbols: Testability and Between-Test Agreement , 2003, Optometry and vision science : official publication of the American Academy of Optometry.
[20] S. Blaser,et al. Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis. , 2001, AJNR. American journal of neuroradiology.
[21] K. North,et al. Optic gliomas in neurofibromatosis type 1: role of visual evoked potentials. , 1994, Pediatric neurology.
[22] R. Chou,et al. Screening for visual impairment in children ages 1-5 years: systematic review to update the 2004 U.S. preventive services task force recommendation , 2011 .
[23] P. Phillips,et al. Optic gliomas in neurofibromatosis type 1: role of visual evoked potentials. , 1995, Pediatric Neurology.